Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Tal Medical management update

    Tal Medical Inc., Boston, Mass. Business: Neurology Hired: Jan Skvarka as president, CEO and a director, formerly a partner at Bain & Company Inc.; he replaces Chairman Steve Paul, who was acting CEO and now transitions…

    Published on 4/14/2014
  • uniQure management update

    uniQure N.V. (NASDAQ:QURE), Amsterdam, the Netherlands Business: Hematology, Neurology, Endocrine/Metabolic Departing: Piers Morgan as CFO, effective May 20 Hired: Eric Goossens as COO, formerly a site director at …

    Published on 4/14/2014
  • 23andMe management update

    23andMe Inc., Mountain View, Calif. Business: Diagnostic Hired: Kathy Hibbs as chief legal and regulatory officer, formerly SVP and general counsel at Genomic Health Inc.

    Published on 4/7/2014
  • Aastrom management update

    Aastrom Biosciences Inc. (NASDAQ:ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy Hired: David Recker as CMO, formerly SVP of clinical sciences at the Takeda Global Research & Development Center Inc. unit of Takeda …

    Published on 4/7/2014
  • Amarantus Bioscience management update

    Amarantus Bioscience Holdings Inc. (OTCQB:AMBS), San Francisco, Calif. Business: Neurology, Cardiovascular Hired: Robert Farrell as CFO, formerly CFO of Sanovas Inc.; he succeeds Marc Faerber, who becomes corporate …

    Published on 4/7/2014
  • Ariad management update

    Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cambridge, Mass. Business: Cancer Hired: Hugh Cole as SVP and CBO, formerly SVP of strategic planning and program management at Shire plc

    Published on 4/7/2014
  • Atossa Genetics management update

    Atossa Genetics Inc. (NASDAQ:ATOS), Seattle, Wash. Business: Diagnostic Hired: Ben Chen as SVP of global regulatory affairs and quality assurance, a newly created position, formerly VP of global quality assurance and …

    Published on 4/7/2014
  • Bio-Path management update

    Bio-Path Holdings Inc. (NASDAQ:BPTH), Houston, Texas Business: Cancer Hired: Ulrich Mueller as COO, formerly a VP at the Fred Hutchinson Cancer Research Center

    Published on 4/7/2014
  • Catalyst Pharma management update

    Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), Coral Gables, Fla. Business: Neurology Hired: Barrett McGrath as chief commercial officer, a newly created position, formerly VP of commercial development at …

    Published on 4/7/2014
  • Cellectar Biosciences management update

    Cellectar Biosciences Inc. (OTCQX:CLRB), Madison, Wis. Business: Cancer, Infectious Transitioned: Simon Pedder, a director, to president and CEO from acting CEO

    Published on 4/7/2014
  • Chembio board of directors update

    Chembio Diagnostics Inc. (NASDAQ:CEMI), Medford, N.Y. Business: Diagnostic Appointed: Katherine Davis, a director, as chairman

    Published on 4/7/2014
  • Cytomedix management update

    Cytomedix Inc. (OTCQX:CMXI), Gaithersburg, Md. Business: Dermatology Hired: Dean Tozer as EVP and chief commercial officer, formerly VP of corporate development at the regenerative medicine unit of Shire plc

    Published on 4/7/2014
  • Cytori management update

    Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA), San Diego, Calif. Business: Gene/Cell therapy, Musculoskeletal Retiring: Christopher Calhoun as CEO, effective immediately, and as a director, effective July 1; he is …

    Published on 4/7/2014
  • Dicerna management update

    Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA), Watertown, Mass. Business: Cancer Hired: Pankaj Bhargava as CMO, formerly associate VP at Sanofi's Sanofi Oncology business

    Published on 4/7/2014
  • Halozyme management update

    Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine/Metabolic, Cancer, Dermatology Resigned: James Shaffer as VP and chief commercial officer

    Published on 4/7/2014
  • Immune Pharmaceuticals management update

    Immune Pharmaceuticals Inc. (OTCQX:IMNP; SSE:IMNP), Tarrytown, N.Y. Business: Cancer, Neurology, Autoimmune Hired: Elliot Goldstein as CMO; and Eugene Williams as COO, formerly CEO of Dart Therapeutics Inc.

    Published on 4/7/2014
  • Insmed management update

    Insmed Inc. (NASDAQ:INSM), Monmouth Junction, N.J. Business: Infectious, Pulmonary Departing: Renu Gupta as EVP of development and CMO in fall 2014

    Published on 4/7/2014
  • Juno Therapeutics management update

    Juno Therapeutics Inc., Seattle, Wash. Business: Cancer Hired: Steve Harr as CFO and head of corporate development, formerly managing director and head of biotechnology investment banking at Morgan Stanley

    Published on 4/7/2014
  • Kite Pharma management update

    Kite Pharma Inc., Los Angeles, Calif. Business: Cancer Transitioned: Arie Belldegrun to president and CEO, while remaining chairman

    Published on 4/7/2014
  • Medivation management update

    Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. Business: Cancer Hired: Rick Bierly as CFO; he succeeds Patrick Machado, who retired

    Published on 4/7/2014
  • NeuroSigma management update

    NeuroSigma Inc., Los Angeles, Calif. Business: Neurology Promoted: Carl Adams to CFO from controller and VP

    Published on 4/7/2014
  • New Haven Pharmaceuticals management update

    New Haven Pharmaceuticals Inc., Guilford, Conn. Business: Cardiovascular, Gastrointestinal Hired: Larry Dillaha as EVP of operations, a newly created position, formerly CMO of Insys Therapeutics Inc.

    Published on 4/7/2014
  • Opko management update

    Opko Health Inc. (NYSE:OPK; Tel Aviv:OPK), Miami, Fla. Business: Ophthalmic, Diagnostic Hired: Arie Gutman as CEO of Opko's newly created active pharmaceutical ingredient and chemical development division, formerly …

    Published on 4/7/2014
  • Par Pharmaceutical management update

    Par Pharmaceutical Cos. Inc., Woodcliff Lake, N.J. Business: Generics Hired: Terrance Coughlin as COO, formerly president and CEO of the North American Glenmark Generics Inc. USA division of Glenmark Pharmaceuticals Ltd…

    Published on 4/7/2014
  • Polaris Pharmaceuticals management update

    Polaris Pharmaceuticals Inc., San Diego, Calif. Business: Cancer, Endocrine/Metabolic Hired: Shaw Chen as EVP of regulatory affairs, formerly deputy director of the Office of Drug Evaluation at FDA's Center for Drug …

    Published on 4/7/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993